Top Buy Now Summary References
Home
>
Section
>
Chapter

Emerging targets in upper tract urothelial carcinomas: the TERT gene

Ortíz Restrepo, A.és.; Ross, J.S.; Spiess, P.E.; Necchi, A.; Li, R.; García-Perdomo, H.A.és.

Canadian Journal of Urology 29(6): 11378-11383

2022

ISSN/ISBN: 1195-9479
PMID: 36495580
Accession: 080716220

Full-Text Article emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Summary
Urothelial carcinoma (UC) is the fourth most prevalent malignancy in adults, accounting for 2.1% of cancer-related deaths. We aimed to describe the most frequent telomerase reverse transcriptase (TERT) gene mutations in this type of cancer and their relationship with the prognosis and treatment of this disease. We performed a search strategy in Medline and Embase with the following keywords: telomerase reverse transcriptase (TERT) gene and upper tract UC. We included reviews and observational studies to support the statements throughout the manuscript. The transcriptional activation of the TERT gene and subsequent telomerase activity is a prerequisite step in malignant transformation and progression. In advanced upper tract UC, TERT mutations are the most common genomic alterations in the Foundation Medicine database. C228T mutations predict distant metastasis in 60% of patients with renal pelvis cancer and 11% with ureteral cancer. Also, C228T and C250T mutations in urine DNA had a sensitivity of 87% and specificity of 94.7%. All TERT genomic alterations are inactivating short variant sequence mutations. There are no copy number gains or losses in TERT and no TERT gene rearrangements or fusions. Multiple markers, and mutations regarding the TERT gene and its promoter have been found in upper tract UC. The C250T and C228T mutations have shown promising results as diagnostic markers detected with urine tests.

References

Wang, K.; Liu, T.; Liu, L.; Liu, J.; Liu, C.; Wang, C.; Ge, N.; Ren, H.; Yan, K.; Hu, S.; Björkholm, M.; Fan, Y.; Xu, D. 2014: TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas Oncotarget 5(7): 1829-1836
Wang, X.; Lopez-Beltran, A.; Osunkoya, A.O.; Wang, M.; Zhang, S.; Davidson, D.D.; Emerson, R.E.; Williamson, S.R.; Tan, P.-H.; Kaimakliotis, H.Z.; Baldridge, L.A.; MacLennan, G.T.; Montironi, R.; Cheng, L. 2017: TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract Future Oncology 13(8): 705-714
Yuan, X.; Meng, Y.; Li, P.; Ge, N.; Kong, F.; Yang, L.; Björkholm, M.; Zhao, S.; Xu, D. 2016: The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population Oncotarget 7(22): 31972-31979
Xing, X.; Yuan, X.; Liu, T.; Dai, M.; Fan, Y.; Liu, C.; Strååt, K.; Björkholm, M.; Xu, D. 2021: Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas Journal of Cancer 12(13): 3853-3861
Kim, M.; Jeong, C.W.; Kwak, C.; Kim, H.H.; Ku, J.H. 2015: Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study Bmc Cancer 15: 149
Wang, K.; Liu, T.; Ge, N.; Liu, L.; Yuan, X.; Liu, J.; Kong, F.; Wang, C.; Ren, H.; Yan, K.; Hu, S.; Xu, Z.; Björkholm, M.; Fan, Y.; Zhao, S.; Liu, C.; Xu, D. 2014: TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR Oncotarget 5(23): 12428-12439
Malouf, G.G.; Compérat, E.; Yao, H.; Mouawad, R.; Lindner, V.; Rioux-Leclercq, N.; Verkarre, V.; Leroy, X.; Dainese, L.; Classe, M.; Descotes, J-Luc.; Barthelemy, P.; Yacoub, M.; Rouprêt, M.; Bernhard, J-Christophe.; Creighton, C.J.; Spano, J-Philippe.; Su, X.; Khayat, D. 2016: Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas Scientific Reports 6: 30988
Aumayr, K.; Klatte, T.; Neudert, B.; Birner, P.; Shariat, S.; Schmidinger, M.; Susani, M.; Haitel, A. 2018: HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas Pathology Oncology Research: Por 24(3): 575-581
Rouprêt, M.; Zigeuner, R.; Palou, J.; Boehle, A.; Kaasinen, E.; Sylvester, R.; Babjuk, M.; Oosterlinck, W. 2012: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract Actas Urologicas Espanolas 36(1): 2-14
Chen, C.-Y.; Liao, Y.-M.; Tsai, W.-M.; Kuo, H.-C. 2007: Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease Journal of the Formosan Medical Association 106(12): 992-998
Jung, V.; Becker, F.; Parr, M.; Hartmann, A.; Füssel, S.; Grobholz, R.; Toma, M.; Wullich, B.; Strauss, A.; Behnes, C.L.; Otto, W.; Stöckle, M.; Junker, K. 2014: Mp23-17 Bellini Duct Carcinomas Have a different Genetic Signature Compared to Urothelial Carcinomas of the Upper Urinary Tract The Journal of Urology 191(4): e249-e250
Zaravinos, A.; Lambrou, G.I.; Mourmouras, N.; Katafygiotis, P.; Papagregoriou, G.; Giannikou, K.; Delakas, D.; Deltas, C. 2014: New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney Plos one 9(3): E91646
Singla, N.; Ghandour, R.A.; Margulis, V. 2019: Sex differences in upper tract urothelial carcinomas Current Opinion in Urology 29(3): 256-260
Martinez Pineiro, J.A.; Garcia Matres, M.J.; Martinez Pineiro, L. 1996: Endourological treatment of upper tract urothelial carcinomas Journal of Urology 155(5 Suppl): 386A
Rouprêt, M.; Colin, P. 2014: Urothelial carcinomas of the upper tract: the myth became a reality Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 24(15): 939-942
Adwan, R. 2020: Upper urinary tract urothelial carcinomas - our experience Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 99(5): 219-225
Sarsik, B.; Doganavsargil, B.; Simsir, A.; Yazici, A.; Pehlivanoglu, B.; Cal, C.; Sen, S. 2016: P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas Pathology Oncology Research: Por 22(4): 839-845
Jhan, J.-H.; Lee, Y.-C.; Li, W.-M.; Chang, L.-L.; Hsu, W.-C.; Lin, H.-H.; Liang, P.-I.; Hsu, Y.-L.; Wu, W.-J.; Lee, H.-Y.; Li, C.-C.; Yeh, H.-C.; Ke, H.-L. 2019: The prognostic value of CSN6 expression in upper tract urothelial carcinomas Kaohsiung Journal of Medical Sciences 35(9): 559-565